# Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors

> **NCT00102830** · PHASE1 · COMPLETED · sponsor: **Amgen**

## Conditions studied

- Tumors

## Interventions

- **DRUG:** AMG 386

## Key facts

- **NCT ID:** NCT00102830
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2010-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00102830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00102830, "Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00102830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*